Inventaire - your friends and communities are your best library

Prostate cancer: ESMO Consensus Conference Guidelines 2012

author

Vesa Kataja

Silke Gillessen

Riccardo Valdagni

1953 -

Gedske Daugaard

1951 -

published in: Annals of Oncology

date of publication: 2013-05

language: English

main subject: prostate cancer

Cites articles 139

Date

Title

Authors

2012-01-06

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

Jonathan Clapp, Timothy R. Church, Claudine Isaacs, Saundra S. Buys, Paul F Pinsky
2012-03-01

Prostate-cancer mortality at 11 years of follow-up

Hans Lilja, Kimmo Taari, Anssi Auvinen, Arnauld Villers, Theodorus H Van der Kwast, Xavier Rebillard, Stefano Ciatto, Teuvo L Tammela, Chris H Bangma, Vera Nelen, Jonas Hugosson, Monique Roobol, Maciej Kwiatkowski, Franz Recker, Marco Zappa
2012-01-05

Infectious complications and hospital admissions after prostate biopsy in a European randomized trial

Stacy Loeb, Monique Roobol
2012-04-30

The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial
2012-04

ESUR prostate MR guidelines 2012

Peter L Choyke
2012-09-01

Intermittent androgen suppression for rising PSA level after radiotherapy

Emma Hall, Padraig Warde, Laurence Klotz, Fred Saad
2012-04-11

The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer

Kimmo Taari
2012-07-01

Radical prostatectomy versus observation for localized prostate cancer

Claus G Roehrborn
2012-02-22

Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer
2012-09-27

Increased survival with enzalutamide in prostate cancer after chemotherapy

Marc Colombel
2011-10-07

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force

Roger Chou
2011-03-31

Randomised prostate cancer screening trial: 20 year follow-up
2011-11-22

Population screening for prostate cancer: an overview of available studies and meta-analysis

Alexandre Mottrie
2011-02-24

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

Hans Lilja, Andrew Vickers
2011-12-28

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group

Monique Roobol, Michael W Kattan, David E. Neal, Donna Ankerst, Arnauld Villers, Daniel M. Moreira, Andrew Vickers, Hans Lilja, Ewout W. Steyerberg, Jonas Hugosson, Jenny L Donovan, Freddie Hamdy, George Bartsch, Helmut Klocker, Wolfgang Horninger, Amine Benchikh, Gilles Salama, Stephen J Freedland
2011-02-23

Advances in magnetic resonance imaging: how they are changing the management of prostate cancer

Hedvig Hricak
2011-12-31

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group

Donna Ankerst, Monique Roobol, Michael W Kattan, David E. Neal, Arnauld Villers, Daniel M. Moreira, Hans Lilja, Andrew Vickers, Jonas Hugosson, Jenny L Donovan, Freddie Hamdy, Angel M Cronin, Helmut Klocker, Wolfgang Horninger, Amine Benchikh, Gilles Salama, Stephen J Freedland, Andreas Boeck
2011-09-20

Active surveillance for prostate cancer: progress and promise

Matthew R Cooperberg, Laurence Klotz
2011-07-22

Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.
2011-03-21

Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration

Marcos Francisco Dall'Oglio, Francesco Montorsi, Alberto Briganti, Shahrokh Shariat, Hendrik van Poppel, Steven Joniau, Robert Jeffrey Karnes, Michael L Blute, Henk van der Poel, Daher C Chade, Guilherme Godoy, Martin E Gleave, James A Eastham, Caroline O. S. Savage
2011-08-15

Androgen deprivation therapy and cardiovascular risk.

Matthew R Cooperberg
2011-11-02

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

Richard A. Cowan, Matthew R Sydes, Padraig Warde
2011-08-05

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

Tommy Nyberg, Gunnar Steineck, Lars Holmberg
2011-11-30

Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer
2011-11-25

Salvage radiotherapy after prostatectomy - what is the best time to treat?
2011-05-05

Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients
2011-04-16

High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
2011-10-12

High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy

Lisa G Horvath, Mark D Chatfield, Phillip D Stricker, Jennifer Turner, James G Kench
2011-02-22

Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis.

Andrea Gallina, Cesare Cozzarini, Umberto Capitanio, Francesco Montorsi, Alberto Briganti, Nadia Di Muzio, Andrea Salonia, Patrizio Rigatti, Nazareno Suardi, Robert Jeffrey Karnes, Manuela Tutolo, Luigi Filippo Da Pozzo, Michael L Blute
2011-11-15

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Karim Fizazi, Fred Saad
2011-06-01

Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response

Mary-Ellen Taplin
2011-05-01

Abiraterone and increased survival in metastatic prostate cancer

Susan Ellard, Fred Saad

Article - wd:Q27022847

Welcome to Inventaire

the library of your friends and communities

learn more